Gateway
Eli Lilly Expands Global Innovation Reach with New Research Centers in China
Eli Lilly, China, Research Centers, Innovation, Gateway Labs, Biotechnology, Drug Development
Eli Lilly Expands Global Footprint with £279 Million Investment in UK’s Biotech Sector
Eli Lilly, Gateway Labs, UK biotech, life sciences, Alzheimer’s treatment, donanemab, investment, healthcare innovation